CIK 0001427570
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Vyome Holdings, Inc
Sign in to watch- Ticker
- HIND
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 949-429-6680
- Business address
- 1001 CALLE AMANECER, SAN CLEMENTE, CA, 92673
- Former names
- ReShape Lifesciences Inc., OBALON THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 1 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-11-09 | Young Donald R VP of Quality Assurance | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2016-11-09 | Fisher Douglas Director | Grant or award · Stock Option (right to buy) | +46,500 | 46,500 | ||
| 2016-11-09 | Brister Mark VP of Research and Development | Grant or award · Stock Option (right to buy) | +90,000 | 90,000 | ||
| 2016-11-09 | VandenBerg Amy VP of Reg. and Clin. Affairs | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2016-11-09 | Stevenson Sharon Director | Grant or award · Stock Option (right to buy) | +46,500 | 46,500 | ||
| 2016-11-09 | Rasdal Andrew P President & CEO | Grant or award · Stock Option (right to buy) | +300,000 | 300,000 | ||
| 2016-11-09 | Plovanic William J. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +55,000 | 55,000 | ||
| 2016-11-09 | Norwood Matthew VP of Sales | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2016-11-09 | Metzner Lisa VP of Marketing | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2016-11-09 | Johnson Steven Ernest VP of Operations | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2016-11-09 | Hussainy Nooshin VP of Finance | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2016-11-09 | HOWE LESLEY H Director | Grant or award · Stock Option (right to buy) | +20,638 | 20,638 | ||
| 2016-11-09 | DITTAMORE RAYMOND V Director | Grant or award · Stock Option (right to buy) | +20,638 | 20,638 | ||
| 2016-11-09 | Kamdar Kim P. Director | Grant or award · Stock Option (Right to Buy) | +46,500 | 46,500 | ||
| 2016-10-12 | DP VII ASSOCIATES LP 10% owner | Conversion | +49,570 | 49,570 | ||
| 2016-10-12 | DP VII ASSOCIATES LP 10% owner | Conversion · Series A Preferred Stock | −11,083 | 0 | ||
| 2016-10-12 | DP VII ASSOCIATES LP 10% owner | Conversion · Series B Preferred Stock | −20,583 | 0 | ||
| 2016-10-12 | DP VII ASSOCIATES LP 10% owner | Conversion · Series C Preferred Stock | −14,271 | 0 | ||
| 2016-10-12 | DOMAIN PARTERS VII L P 10% owner | Conversion | +3,985,970 | 3,985,970 | ||
| 2016-10-12 | DOMAIN PARTERS VII L P 10% owner | Conversion · Series A Preferred Stock | −649,835 | 0 |
Page 15 of 17 · 322 trades